OR WAIT null SECS
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Estonia, Hungary, and Iceland have signed up to take part in a pilot of Guardtime's VaccineGuard—a newly developed platform aimed at supporting the global COVID-19 vaccination program.
European deep tech company, Guardtime, has revealed that Estonia, Hungary, and Iceland have signed up to take part in a pilot of VaccineGuard—a newly developed platform aimed at supporting the global COVID-19 vaccination program.
“We are delighted that Iceland, Estonia, and Hungary have agreed to pilot our new platform,” said Ain Aaviksoo, chief medical officer, Guardtime, in a Jan. 18, 2021 press release. “These countries have been among the most proactive and most successful in developing state of the art tools and strategies for addressing Coronavirus, and we look forward to working with them on this project and sharing the findings with other countries and stakeholders to get soon back to normalcy.”
AstraZeneca Estonia will be involved in VaccineGuard product testing, enabling an end-to-end solution with a feedback loop between all participants in the network. The product pilot will be based on a six-month collaboration with the Estonian government and the World Health Organization (WHO) and is expected to be taken up by additional governments in the near future.
Through this pilot program, the Estonian government will be fulfilling an integral part of its offer to WHO and its member states to share experiences of how distributed information architecture and interoperability can be used in the fight against COVID-19.
Jüri Ratas, prime minister of Estonia added in the press release, “The pandemic has shown the world that in crisis we need to have a global anchor of trust like the WHO. [WHO] can play a critical positive role in global digital health governance. Our pilot project presents an extraordinary opportunity for the Estonian community to help the world in the fight against COVID-19.”
Source: Guardtime
Related Content: